Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Cyr, Derek D ^a   Lucas, Joseph E ^a   Thompson, J Will ^a   Patel, Keyur ^a   Clark, Paul J ^a   Thompson, Alexander ^a   Tillmann, Hans L ^a   McHutchison, John G ^a   Moseley, M Arthur ^a   McCarthy, Jeanette J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HEMOPROTEIN; INTERLEUKIN 28B; PROTEIN; PROTEIN AFAM; TRANSCORTIN; TRYPSIN; UNCLASSIFIED DRUG; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; PLASMA PROTEIN; SERPINA6 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID BLOOD LEVEL; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERLEUKIN 28B GENE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VIRAL CLEARANCE; ANALYSIS OF VARIANCE; BLOOD; COHORT ANALYSIS; GENE FREQUENCY; GENETICS; METHODOLOGY; MIDDLE AGED;

HEPATITIS C VIRUS;

ADULT; ANALYSIS OF VARIANCE; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKINS; MALE; MASS SPECTROMETRY; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOMICS; TRANSCORTIN;

EID: 79960022080     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021854     Document Type: Article

References (26)

1. The Global Burden of Hepatitis C Working Group (2004) Global burden of disease (GBD) for hepatitis C. Jour Clin Pharmacol 44: 20-29 doi:10.1177/0091270003258669.
2. Brown RS, (2005) Hepatitis C and liver transplantation. Nature 436: 973-978.
3. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801 doi:10.1038/nature08463.
4. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401 doi:10.1038/nature08309.
5. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
6. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
7. Rauch A, Kutalik Z, Descombes P, Cai T, Di lulio J, et al. (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138 (4): 1338-1345,1345.e1-7.
8. Sarasin-Filipowicz M, Oakeley EJ, Duong FHT, Christen V, Terracciano L, et al. (2008) Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A 105: 7034-7039.
9. Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, et al. (2010) Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 139 (2): 499-509.
10. Urban TJ, Thompson AJ, Bradrick SS, Fellay J, Schuppan D, et al. (2010) IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 52 (6): 1888-1896 doi:10.1002/hep.23912.
11. Patel K, Lucas J, Thompson JW, Moseley MA, Uzarski D, et al. (2011) High predictive accuracy of an unbiased proteomic profile to predict sustained virologic response in genotype 1 chronic hepatitis C patients. Hepatology. In press.
12. Foss EJ, Radulovic D, Shaffer SA, Ruderfer, DM, Bedalov A, et al. (2007) Genetic basis of proteome variation in yeast. Nat Genet 39: 1369-1375.
13. Melzer D, Perry JRB, Hernandez D, Corsi A-M, Stevens K, et al. (2008) A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 4 (5): e1000072 doi:10.1371/journal.pgen.1000072.
14. McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, et al. (2010) Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 138 (7): 2307-2314.
15. Dhillo WS, Kong WM, Le Roux CW, Alaghband-Zadeh J, Jones J, et al. (2002) Cortisol-binding globulin is important in the interpretation of dynamic tests of the hypothalamic-pituitary-adrenal axis. Eur Jour Endocrinol 146 (2): 231-235 doi:10.1530/eje.0.1460231.
16. Fernandez-Real JM, Pugeat M, Grasa M, Broch M, Vendrell J, et al. (2002) Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study. Jour Clin Endocrinol Metab 87 (10): 4686-4690 doi:10.1210/jc.2001-011843.
17. Ohno Y, Fujimoto M, Nishimura A, Aoki N, (1998) Change of peripheral levels of pituitary hormones and cytokines after injection of interferon (IFN)-beta in patients with chronic hepatitis C. Jour Clin Endocrinol Metab 83 (10): 3681-3687.
18. Raison CL, Borisov AS, Woolwine BJ, Massung B, Vogt G, et al. (2010) Interferon-α effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry 15: 535-547 doi:10.1038/mp.2008.58.
19. Vincent RP, Etogo-Asse FE, Dew T, Bernal W, Alaghband-Zadeh J, et al. (2009) Serum total cortisol and free cortisol index give different information regarding the hypothalamus-pituitary-adrenal axis reserve in patients with liver impairment. Ann Clin Biochem 46: 505-507 doi:10.1258/acb.2009.009030.
20. Charlton MR, Thompson A, Veldt BJ, Watt K, Tillmann H, et al. (2011) Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology 53 (1): 317-324.
21. Crave JC, Lejeune H, Brebant C, Baret C, Pugeat M, (1995) Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells. Jour Clin Endocrinol Metab 80: 1283-1289 doi:10.1210/jc.80.4.1283.
22. Fernandez-Real JM, Grasa M, Casamitjana R, Pugeat M, Barret C, et al. (1999) Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion. Jour Clin Endocrinol Metab 84 (9): 3192-3196 doi:10.1210/jc.84.9.3192.
23. Metz TO, Qian WJ, Jacobs JM, Gritsenko MA, Moore RJ, et al. (2008) Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset. Jour Proteome Res 7 (2): 698-707.
24. Romero-Gómez M, Del Mar Viloria M, Andrade RJ, Salmerón J, Diago M, et al. (2005) Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128 (3): 636-641.
25. Gagliardi L, Ho JT, Torpy DJ, (2010) Corticosteroid-binding globulin: the clinical significance of altered levels and heritable mutations. Mol Cell Endocrinol 316 (1): 24-34.
26. Livak KJ, (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14: 143-149.